UCB - 판매 수익





매상 변화 날짜
Alcon AG USD 2.69B 10M 2026-03
Almirall EUR 547.63M 12.83M 2025-12
Amarin USD 49.22M 451K 2025-12
argenx SE USD 1.12B 0 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.7B 280M 2026-03
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Novartis USD 13.11B 226M 2026-03
Orion EUR 417.7M 277.6M 2026-03
Recordati EUR 713.42M 51.42M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Unibail Rodamco EUR 1.49B 77M 2025-12